Timing, hosts and locations of (grouped) events of NanoImpactNet

More documents

Recommendations

Info

NanoSafetyCluster - Compendium 2012 has been updated, new methods have been, and continuously will be included. EURO-NanoTox is the AUSTRIAN hub for nanotoxicology and serves as the port for all scientific driven aspects of nanotoxicology and human health. In future, EURO-NanoTox will additionally serve as a scientific foundation for regulatory aspects as for example worker safety/workplace safety. To enhance safety for workers EURO- NanoTox actively tested workplaces and assessed the risk and safety aspects at these workplaces. The EURO-NanoTox partners additionally provide valid scientific data and perform validated scientific experiments to address the potential toxic profile of nano-structured materials. Extract of the publications from EURO- NanoTox and its partners: Fröhlich E. and Roblegg E. (2011) Risk of oral exposure to nanoparticles in consumer products. Toxicology, 2011, in press. Fröhlich, E; Meindl, C; Pieber, TR. (2010) Important issues in the cytotoxicity screening of nano-sized materials. ENT-Letters 2(2010) pp.1-8. Roblegg, E.; Falk, A.; Fröhlich, E.; Zimmer, A.; Sinner F. (2011) European Centre for Nanotoxicology: A Proactive Risk-assessment Nanotechnology Initiative. ASM Science Journal, Volume 5(1), pp.43-52. Roblegg, E; Fröhlich, E; Meindl, C; Teubl, B; Zaversky, M; Zimmer, A (2011) Evaluation of a physiological in vitro system to study the transport of nanomaterials through the buccal mucosa. Nanotoxicology, May 18. [Epub ahead of print] Fröhlich, E.; Meindl, C.; Roblegg, E; Griesbacher, A; Pieber, TR (2011) Cytotoxity of nanoparticles is influenced by size, proliferation and embryonal origin of the cells used for testing. Nanotoxicology, May 31. [Epub ahead of print] Furthermore, EURO-NanoTox is setting up a European-wide network of national hubs for nanotoxicology in collaboration with already existing platforms. This network will help to interchange recent developments and developed methods between different European countries and promote the development of European standards to help ensuring the successful development of nanotechnologies as a key for European growth. EURO-NanoTox actively contributes to European projects dealing with regulatory aspects of nanotechnology (e.g. NANOFORCE) and plans to enlarge its initiative in this field in future projects. 32 Compendium of Projects in the European NanoSafety Cluster
8 Directory Table 1 Directory of people involved in this project. First Name Last Name Affiliation Address e-mail Albert Duschl University Salzburg, Department Molecular Biology NanoSafetyCluster - Compendium 2012 Hellbrunnerstrasse 34, 5020 Salzburg, Austria Andreas Falk (project manager) BioNanoNet Forschungsgesellschaft mbH Elisabethstraße 9-11, 8010 Graz, Austria Eleonore Fröhlich Medical University Graz Stiftingtalstrasse 24, 8010 Graz, Austria Franz Gabor University of Vienna, Faculty of Life Sciences, Department of Pharmaceutical Technology and Biopharmaceutics Andreas Kornherr Mondi Uncoated Kraft & Fine Papers GmbH Althanstrasse 14, 1090 Vienna, Austria Haidmühlstraße 2-4, 3363 Ulmerfeld- Hausmening, Austria Mohammed Reza Lornejad-Schäfer BioMed-zet-Life Sciences GmbH Industriezeile 36/I, 4020 Linz, Austria Eva Roblegg Institute of Pharmaceutical Sciences/ Pharmaceutical Technology, Karl- Franzens University of Graz Universitätsplatz 1, 8010 Graz, Austria Frank Sinner (Coordinator) JOANNEUM RESEARCH - HEALTH Elisabethstraße 11a, 8010 Graz, Austria Andreas Zimmer Institute of Pharmaceutical Sciences/ Pharmaceutical Technology, Karl- Franzens University of Graz 9 Copyright © 2012, BioNanoNet Forschungsgesellschaft mbH, Austria Universitätsplatz 1, 8010 Graz, Austria Albert.Duschl@sbg.ac.at Andreas.falk@bionanonet.at eleonore.froehlich@klinikum-graz.at Franz.gabor@univie.ac.at Andreas.kornherr@mondigroup.com lornejad@zet.or.at Eva.roblegg@uni-graz.at Frank.sinner@joanneum.at Andreas.zimmer@uni-graz.at This is an Open Access document distributed under the terms of the Creative Commons Attribution-NonCommercial Unported License. (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Anyone is free: • to Share — to copy, distribute and transmit the work • to Remix — to adapt the work Under the following conditions: • Noncommercial — You may not use this work for commercial purposes. • Attribution. • EuroNanoTox must be given credit, but not in any way that suggests that they endorse you or your use of the work; • For any reuse or distribution, you must make clear to others the license terms of this work. The best way to do this is with a link to this web page: http://creativecommons.org/licenses/by-nc/3.0/. Statutory fair use and other rights are in no way affected by the above. Compendium of Projects in the European NanoSafety Cluster 33
Page 1: Compendium of Projects in the Europ
Page 5 and 6: EDITED BY Michael Riediker, PD Dr.s
Page 7 and 8: CONTENTS NanoSafetyCluster - Compen
Page 9 and 10: Project Acronym ENNSATOX ENPRA EURO
Page 11 and 12: Foreword NanoSafetyCluster - Compen
Page 13 and 14: ENNSATOX ENgineered Nanoparticle Im
Page 15 and 16: The biological membrane and its dep
Page 17 and 18: distinguishes between the interacti
Page 19 and 20: Figure 10. Schematic representation
Page 21 and 22: WP5: • Permeability of NPs in hyd
Page 23 and 24: NanoSafetyCluster - Compendium 2012
Page 25 and 26: ENPRA RISK ASSESSMENT OF ENGINEERED
Page 27 and 28: vitro findings with in vivo models;
Page 29 and 30: protocols with real biological samp
Page 31 and 32: and it was organised in the frame o
Page 33 and 34: First Name Last Name Affiliation Ad
Page 37 and 38: EURO-NanoTox European Center for Na
Page 39 and 40: silver nanoparticles, iron nanopart
Page 41: The core functions of the Center, h
Page 45 and 46: HINAMOX Health Impact of Engineered
Page 47 and 48: High Resolution Electron Microscopy
Page 49 and 50: integrated risk assessment. Integra
Page 51 and 52: powders: What is the difference in
Page 57 and 58: InLiveTox Intestinal, Liver and End
Page 59 and 60: - to develop and validate a novel m
Page 61 and 62: environments, IEEE Industrial Elect
Page 63 and 64: INSTANT Innovative Sensor for the f
Page 65 and 66: complementary research which will l
Page 67 and 68: 7 Copyright NanoSafetyCluster - Com
Page 69 and 70: ITS-NANO Intelligent testing strate
Page 71 and 72: approach to conveying the appropria
Page 73 and 74: in the discussion. The integration
Page 75 and 76: MARINA MANAGING RISKS of NANOMATERI
Page 77 and 78: for risk analysis, these tools need
Page 79 and 80: environmental ENM toxicity, but tox
Page 81 and 82: propose it as a Method Validation F
Page 83 and 84: and SiO2-NM200 and NM203, and a SiO
Page 85 and 86: ModNanoTox Modelling nanoparticle t
Page 87 and 88: 3) To model environmental exposure
Page 89 and 90: Nanodetector European Network on th
Page 91 and 92: measurement interval. Measurements
Page 93 and 94:
5 Directory Table 1 Directory of pe
Page 95 and 96:
NANODEVICE Novel Concepts, Methods,
Page 97 and 98:
ENP in order to be sure of their sa
Page 99 and 100:
4.3 Exploring the association betwe
Page 101 and 102:
NanoSafetyCluster - Compendium 2012
Page 103 and 104:
NanoFATE Nanoparticle Fate Assessme
Page 105 and 106:
or proteins associated with particu
Page 107 and 108:
sludge. Information on rates of slu
Page 109 and 110:
The exposures to be conducted will
Page 111:
NanoFATE progression beyond the “
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
NanoSafetyCluster ‐ Compendium 20
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288:
show all

Timing, hosts and locations of (grouped) events of NanoImpactNet

Create successful ePaper yourself

Delete template?

Save as template?